Skip to main content
. 2014 Aug;88(15):8349–8354. doi: 10.1128/JVI.00924-14

TABLE 2.

Characteristics of HIV-1-infected subjects enrolled in the GSK vaccine trial

Characteristic Value for:
Entire study population (n = 13) Study population by treatment group
Vaccine (n = 8) Placebo/adjuvant (n = 5)
Age (median, yr) 48 49 41
Gender (% male) 69 50 100
Median duration of ARTa (yr) 11 11 11
Median baseline CD4 cell counts (/mm3) 760 768 731
a

Before study entry.